Total Payments
$15,321
2024 Payments
$2,458
Companies
72
Transactions
1,077
Medicare Patients
7,772
Medicare Billing
$448,414
Payment Breakdown by Category
Food & Beverage$15,315 (100.0%)
Education$6.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,315 | 1,076 | 100.0% |
| Education | $6.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,449 | 127 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,435 | 70 | $0 (2024) |
| ABBVIE INC. | $977.47 | 69 | $0 (2024) |
| GlaxoSmithKline, LLC. | $938.62 | 71 | $0 (2024) |
| Amgen Inc. | $771.41 | 52 | $0 (2024) |
| Lilly USA, LLC | $763.97 | 56 | $0 (2024) |
| Daiichi Sankyo Inc. | $723.60 | 35 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $638.95 | 41 | $0 (2024) |
| PFIZER INC. | $605.00 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $595.81 | 70 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,458 | 141 | Novo Nordisk Inc ($265.46) |
| 2023 | $2,425 | 140 | Daiichi Sankyo Inc. ($212.85) |
| 2022 | $2,241 | 133 | ABBVIE INC. ($244.12) |
| 2021 | $1,686 | 121 | Novo Nordisk Inc ($241.89) |
| 2020 | $1,583 | 116 | Novo Nordisk Inc ($192.22) |
| 2019 | $1,953 | 148 | Novo Nordisk Inc ($272.49) |
| 2018 | $1,430 | 128 | AstraZeneca Pharmaceuticals LP ($219.73) |
| 2017 | $1,546 | 150 | GlaxoSmithKline, LLC. ($181.52) |
All Payment Transactions
1,077 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Obesity | ||||||
| 12/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Gastroenterology | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Biological | ||||||
| 12/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Bone Health | ||||||
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.82 | General |
| 11/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.76 | General |
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Obesity | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Biological | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: PAIN | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Bone Health | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,805 | 3,524 | $349,906 | $122,189 |
| 2022 | 33 | 1,828 | 3,682 | $347,229 | $119,825 |
| 2021 | 28 | 1,951 | 2,723 | $294,136 | $97,377 |
| 2020 | 30 | 2,188 | 4,151 | $350,975 | $109,022 |
Total Patients
7,772
Total Services
14,080
Medicare Billing
$448,414
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 221 | 557 | $144,820 | $46,127 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 145 | 145 | $42,775 | $17,356 | 40.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,020 | $39,300 | $17,264 | 43.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 58 | $20,300 | $7,138 | 35.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 93 | 94 | $15,345 | $7,039 | 45.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $8,130 | $3,663 | 45.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 156 | 191 | $10,505 | $3,144 | 29.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 185 | 303 | $9,090 | $3,136 | 34.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 96 | 97 | $5,723 | $2,829 | 49.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 15 | 15 | $6,675 | $2,345 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 42 | $7,350 | $2,259 | 30.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 122 | 138 | $6,210 | $1,811 | 29.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 159 | 219 | $6,351 | $1,667 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 75 | 121 | $4,235 | $1,142 | 27.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 51 | 58 | $3,770 | $1,045 | 27.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 25 | 28 | $2,660 | $812.28 | 30.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 41 | 41 | $2,255 | $605.98 | 26.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 56 | $7,237 | $541.63 | 7.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 57 | $684.00 | $478.80 | 70.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 39 | 50 | $1,600 | $442.00 | 27.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $767.00 | $379.21 | 49.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 23 | 24 | $1,560 | $326.61 | 20.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 86 | 98 | $882.00 | $213.85 | 24.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 14 | 18 | $648.00 | $163.38 | 25.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 31 | 34 | $476.00 | $105.74 | 22.2% |
About Dr. Aleksei Plotnikov, M.D
Dr. Aleksei Plotnikov, M.D is a Internal Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083671036.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aleksei Plotnikov, M.D has received a total of $15,321 in payments from pharmaceutical and medical device companies, with $2,458 received in 2024. These payments were reported across 1,077 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($15,315).
As a Medicare-enrolled provider, Plotnikov has provided services to 7,772 Medicare beneficiaries, totaling 14,080 services with total Medicare billing of $448,414. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Greensboro, NC
- Active Since 04/26/2006
- Last Updated 10/18/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1083671036
Products in Payments
- Ozempic (Drug) $711.55
- INJECTAFER (Drug) $707.85
- JARDIANCE (Drug) $575.16
- FARXIGA (Drug) $543.64
- EVENITY (Biological) $531.78
- VRAYLAR (Drug) $492.05
- XARELTO (Drug) $484.82
- XIFAXAN (Drug) $456.76
- TRELEGY ELLIPTA (Drug) $413.14
- NURTEC ODT (Drug) $357.48
- LINZESS (Drug) $335.91
- NUZYRA (Drug) $259.73
- MOUNJARO (Drug) $253.48
- ANORO (Drug) $235.68
- BYDUREON (Drug) $234.21
- Vascepa (Drug) $227.95
- BREZTRI (Drug) $221.50
- Wegovy (Drug) $205.56
- Linzess (Drug) $205.25
- XYOSTED (Drug) $191.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greensboro
Dr. Daniel Bensimhon, Md, MD
Internal Medicine — Payments: $2.3M
Internal Medicine $2.3M
Dr. Michael Wert, M.d, M.D
Internal Medicine — Payments: $439,242
Internal Medicine $439,242
Mark Russo, Md, MD
Internal Medicine — Payments: $318,372
Internal Medicine $318,372
Julian Hutchins, Md, MD
Internal Medicine — Payments: $222,266
Internal Medicine $222,266
Dr. James Beekman, Md, MD
Internal Medicine — Payments: $116,445
Internal Medicine $116,445
Walter Pharr, M.d, M.D
Internal Medicine — Payments: $53,823
Internal Medicine $53,823